AN1 0.00% 0.8¢ anagenics limited

Ann: Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement, page-1065

  1. Osi
    16,414 Posts.
    lightbulb Created with Sketch. 201

    In contrast Cellmid:

    - has extensive diagnostics experience;
    - board members and scientific advisors who are capable and trusted by Government to complete an internal results based study of the Wondfo POCTS.
    - is commencing with a relative small order of tests, thus keeping the company's risk exposure down.

    I want to see the Cellmid under promise and over deliver (not the other way around).

    On the POCTS themselves, they need to be used only for their intended purpose and very carefully by trained health care workers. Rough-house use in the field will lead to inaccurate results with most test including this one.


 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.